BioTelemetry trades as part of the healthcare sector and trades as part of the medical diagnostics and research industry. The company CEO is Joseph H. Capper. BioTelemetry Inc provides monitoring services and digital population health management for healthcare providers, medical device manufacturing and centralized core laboratory services for clinical research.
Previous Intraday Trading Performance:
The BEAT stock showed a previous change of 2.35% with an open at 69.32 and a close of 70.25. It reached an intraday high of 71.10 and a low of 68.76.
The stock has a market cap of $2.4b with 33.6m shares outstanding, of which the float is 31.4m shares. Trading volume reached 716,755 shares compared to its average volume of 770,059 shares. Based on the current average volume and close price, the trading liquidity is good.
Historical Trading Performance:
Over the last five trading days, BioTelemetry shares returned 4.55% and in the past 30 trading days it returned 0.54%. Over three months, it changed 5.78%. In one year it has changed 95.68% and within that year its 52-week high was 80.92 and its 52-week low was 29.85. BEAT stock is 135.34% above its 52 Week Low.
Our calculations show a 200 day moving average of 58.86 and a 50 day moving average of 69.20. Currently BEAT stock is trading 19.35% above its 200 day moving average.
The last annual fiscal EPS for the company was reported at 1.94 that ended on 31st of December 2018, which according to the previous close, that is a PE of 58.54. Based on 4 analyst estimates, the consensus EPS for the next quarter is 0.42. The TTM EPS is 1.94, which comes to a TTM PE of 36.21.
The following are the last four quarter reported earnings per share:
Base on our calculations, the intrinsic value per share is 81.29, which means it is possibly undervalued and has a margin of safety of 13.58%
Indicators to Watch:
Based on the latest filings, there is 135.50% of institutional ownership. Short-interest is 0, which is 0.00% of shares outstanding. The short-interest ratio or days-to-cover ratio is 0.00.
The current calculated beta is 1.47
SeekingAlpha: CARBO Ceramics misses by $0.25, beats on revenue
Based on last reported financials, the company’s return on equity is 15.56%, return on assets is 7.86%, profit margin is 10.83%, price-to-sales is 5.88 and price-to-book is 7.43.
All scores are out of six:
0 :Valuation Score
2 :Past Performance Score
3 :Financial Strength Score
3 :Future Growth Score
0 :Dividend Score
2 :Overall Score